Browsing by Author "Forbes, A."
Now showing items 1-5 of 5
-
Anti-GP2 antibodies in inflammatory bowel disease patients with ileal pouch
Pavlidis, P.; Forbes, A.; Bogdanos, D. P. (2013) -
Diagnostic and clinical significance of Crohn's disease-specific anti-MZGP2 pancreatic antibodies by a novel ELISA
Pavlidis, P.; Shums, Z.; Koutsoumpas, A. L.; Milo, J.; Papp, M.; Umemura, T.; Lakatos, P. L.; Smyk, D. S.; Bogdanos, D. P.; Forbes, A.; Norman, G. L. (2015)Background: We developed a new IgA and IgG anti-MZGP2 antibody ELISAs based on recombinant isoform-4 of human zymogen granule protein-2 (GP2), which is the major autoantigen of Crohn's disease (CrD)-specific pancreatic ... -
Diagnostic value, clinical utility and pathogenic significance of reactivity to the molecular targets of Crohn's disease specific-pancreatic autoantibodies
Bogdanos, D. P.; Rigopoulou, E. I.; Smyk, D. S.; Roggenbuck, D.; Reinhold, D.; Forbes, A.; Laass, M. W.; Conrad, K. (2011)Pancreatic autoantibodies (PAB) giving characteristic staining patterns of the exocrine pancreas by indirect immunoflourescence appear to be specific markers of Crohn's disease (CrD), being present in approximarely 30% of ... -
Ileal InflammationMay Trigger the Development of GP2-Specific Pancreatic Autoantibodies in Patients with Crohn's Disease
Pavlidis, P.; Romanidou, O.; Roggenbuck, D.; Mytilinaiou, M. G.; Al-Sulttan, F.; Liaskos, C.; Smyk, D. S.; Koutsoumpas, A. L.; Rigopoulou, E. I.; Conrad, K.; Forbes, A.; Bogdanos, D. P. (2012)Why zymogen glycoprotein 2 (GP2), the Crohn's disease (CD)-specific pancreatic autoantigen, is the major target of humoral autoimmunity in inflammatory bowel diseases (IBD) is uknown. Recent evidence demonstrates that GP2 ... -
Peculiar antibody reactivity to human connexin 37 and its microbial mimics in patients with Crohn's disease
Koutsoumpas, A.; Polymeros, D.; Tsiamoulos, Z.; Smyk, D.; Karamanolis, G.; Triantafyllou, K.; Rigopoulou, E. I.; Forbes, A.; Vergani, D.; Bogdanos, D. P.; Ladas, S. D. (2011)Background/aims: We found that pooled Crohn's disease (CD) sera strongly react with a human gap-junction connexin 37 (Cx37) peptide and tested for anti-Cx37 antibody reactivity in sera from CD patients and controls. We ...